These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 23144745)

  • 21. The hepcidin gene promoter nc.-1010C > T; -582A > G haplotype modulates serum ferritin in individuals carrying the common H63D mutation in HFE gene.
    Silva B; Pita L; Gomes S; Gonçalves J; Faustino P
    Ann Hematol; 2014 Dec; 93(12):2063-6. PubMed ID: 25015054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of alcohol consumption on iron metabolism in mice with hemochromatosis mutations.
    Flanagan JM; Peng H; Beutler E
    Alcohol Clin Exp Res; 2007 Jan; 31(1):138-43. PubMed ID: 17207112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Iron overload and insulin resistance].
    Vantyghem MC; Girardot C; Boulogne A; Wemeau JL
    Presse Med; 2005 Nov; 34(19 Pt 1):1391-8. PubMed ID: 16292193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatic iron content is independently associated with serum hepcidin levels in subjects with obesity.
    Moreno-Navarrete JM; Moreno M; Puig J; Blasco G; Ortega F; Xifra G; Ricart W; Fernández-Real JM
    Clin Nutr; 2017 Oct; 36(5):1434-1439. PubMed ID: 27745814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepcidin expression in iron overload diseases is variably modulated by circulating factors.
    Ravasi G; Pelucchi S; Trombini P; Mariani R; Tomosugi N; Modignani GL; Pozzi M; Nemeth E; Ganz T; Hayashi H; Barisani D; Piperno A
    PLoS One; 2012; 7(5):e36425. PubMed ID: 22586470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Iron and the liver.
    Pietrangelo A
    Liver Int; 2016 Jan; 36 Suppl 1():116-23. PubMed ID: 26725908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepcidin levels in diabetes mellitus and polycystic ovary syndrome.
    Sam AH; Busbridge M; Amin A; Webber L; White D; Franks S; Martin NM; Sleeth M; Ismail NA; Daud NM; Papamargaritis D; Le Roux CW; Chapman RS; Frost G; Bloom SR; Murphy KG
    Diabet Med; 2013 Dec; 30(12):1495-9. PubMed ID: 23796160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inadequate hepcidin serum concentrations predict incident type 2 diabetes mellitus.
    Pechlaner R; Weiss G; Bansal S; Mayr M; Santer P; Pallhuber B; Notdurfter M; Bonora E; Willeit J; Kiechl S
    Diabetes Metab Res Rev; 2016 Feb; 32(2):187-92. PubMed ID: 26378394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepcidin levels correlate to liver iron content, but not steatohepatitis, in non-alcoholic fatty liver disease.
    Marmur J; Beshara S; Eggertsen G; Onelöv L; Albiin N; Danielsson O; Hultcrantz R; Stål P
    BMC Gastroenterol; 2018 Jun; 18(1):78. PubMed ID: 29871592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Behavioral, biochemical, and genetic analysis of iron metabolism in high-intensity blood donors.
    Mast AE; Foster TM; Pinder HL; Beczkiewicz CA; Bellissimo DB; Murphy AT; Kovacevic S; Wroblewski VJ; Witcher DR
    Transfusion; 2008 Oct; 48(10):2197-204. PubMed ID: 18657084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemochromatosis and iron-overload screening in a racially diverse population.
    Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P;
    N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic iron metabolism gene expression profiles in HFE associated hereditary hemochromatosis.
    Gleeson F; Ryan E; Barrett S; Russell J; Crowe J
    Blood Cells Mol Dis; 2007; 38(1):37-44. PubMed ID: 17098454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating Iron Levels Interaction with Central Obesity on the Risk of Nonalcoholic Fatty Liver Disease: A Case-Control Study in Southeast China.
    Pan X; Chen B; Liu W; Li Y; Hu Z; Lin X; Xu S; Peng XE
    Ann Nutr Metab; 2019; 74(3):207-214. PubMed ID: 30870854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in the Serum Hepcidin-to-ferritin Ratio with Erythroferrone after Hepatitis C Virus Eradication Using Direct-acting Antiviral Agents.
    Inomata S; Anan A; Yamauchi E; Yamauchi R; Kunimoto H; Takata K; Tanaka T; Yokoyama K; Morihara D; Takeyama Y; Irie M; Shakado S; Sohda T; Sakisaka S
    Intern Med; 2019 Oct; 58(20):2915-2922. PubMed ID: 31243222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hereditary hemochromatosis: insights from the Hemochromatosis and Iron Overload Screening (HEIRS) Study.
    McLaren GD; Gordeuk VR
    Hematology Am Soc Hematol Educ Program; 2009; ():195-206. PubMed ID: 20008199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mild iron overload in patients carrying the HFE S65C gene mutation: a retrospective study in patients with suspected iron overload and healthy controls.
    Holmström P; Marmur J; Eggertsen G; Gåfvels M; Stål P
    Gut; 2002 Nov; 51(5):723-30. PubMed ID: 12377814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased risk of death from iron overload among 422 treated probands with HFE hemochromatosis and serum levels of ferritin greater than 1000 μg/L at diagnosis.
    Barton JC; Barton JC; Acton RT; So J; Chan S; Adams PC
    Clin Gastroenterol Hepatol; 2012 Apr; 10(4):412-6. PubMed ID: 22265917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dysmetabolic hyperferritinemia is associated with normal transferrin saturation, mild hepatic iron overload, and elevated hepcidin.
    Chen LY; Chang SD; Sreenivasan GM; Tsang PW; Broady RC; Li CH; Zypchen LN
    Ann Hematol; 2011 Feb; 90(2):139-43. PubMed ID: 20721554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Iron Stores, Hepcidin, and Aortic Stiffness in Individuals with Hypertension.
    Valenti L; Maloberti A; Signorini S; Milano M; Cesana F; Cappellini F; Dongiovanni P; Porzio M; Soriano F; Brambilla M; Cesana G; Brambilla P; Giannattasio C; Fargion S
    PLoS One; 2015; 10(8):e0134635. PubMed ID: 26244503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hyperferritinemia-cataract syndrome associated to the HFE gene mutation. Two new Spanish families and a new mutation (A37T: "Zaragoza")].
    García Erce JA; Cortés T; Cremonesi L; Cazzola M; Pérez-Lungmus G; Giralt M
    Med Clin (Barc); 2006 Jun; 127(2):55-8. PubMed ID: 16900584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.